Breaking News
RBC Capital Analyst Lowers Price Target for PTC Therapeutics due to European Drug Rejection
On January 27, 2024, esteemed analyst Brian Abrahams from RBC Capital made a notable decision regarding PTC Therapeutics (NASDAQ: PTCT)....
Levi Strauss Co Releases FourthQuarter Results with Surpassing Earnings Expectations
On January 27, 2024, Levi Strauss & Co (NYSE: LEVI) released its fourth-quarter results, which led to a decline in...
Gentex Corporation Surpasses Expectations with Exceptional Q4 Financial Results
Gentex Corporation has delivered exceptional financial results for the fourth quarter of 2023, surpassing market expectations and prompting a surge...
Vera Therapeutics Surging Stock Price and Ambitious Price Target
On January 27, 2024, Vera Therapeutics experienced a remarkable surge in its stock price, propelled by the release of promising...
Strong Q4 Financial Results Drive Up The Bancorps Stock Price
The Bancorp's stock is experiencing an upswing following the release of their impressive Q4 sales figures. It seems that numerous...
Norfolk Southern Corporations Fourth Quarter 2023 Financial Results and Future Outlook
On January 27, 2024, Norfolk Southern Corporation (NSC) unveiled its financial results for the fourth quarter of 2023, which fell...
Corbus Pharmaceuticals Holdings Inc Surges on Promising Drug Candidate CRB701
On January 27, 2024, Corbus Pharmaceuticals Holdings, Inc. made an exciting revelation about its drug candidate CRB-701, leading to a...
Insider Activity at Minerals Technologies Raises Questions about Stock Options
As of January 27, 2024, there has been notable insider activity at Minerals Technologies (NYSE: MTX). Key executives, including Michael...
RBC Capital Reaffirms Fair Isaac with Sector Perform Rating and 1350 Price Target
As of January 27, 2024, no substantial details have been found regarding RBC Capital's reaffirmation of Fair Isaac. Their stance...
Analyst Reiterates Buy Rating for Virtu Financial with Adjusted Price Target
On January 27, 2024, Christopher Allen, an analyst at Citigroup, expressed his optimism for Virtu Financial (NASDAQ: VIRT) by reiterating...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
